AstraZeneca PLC is 98.5x more valuable than Arcutis Biotherapeutics, Inc. by market capitalization ($286.27 B vs $2.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARQT | AZN |
|---|---|---|
| Market cap | $2.91 B | $286.27 B |
| US-listed rank | #1831 | #45 |
| Revenue (latest FY) | $376.07M | - |
| Net income (latest FY) | -$16.14M | - |
| Net margin | -4.3% | - |
| SEC filings | 798 | 1,004 |
AstraZeneca PLC is 98.5x more valuable than Arcutis Biotherapeutics, Inc. by market capitalization ($286.27 B vs $2.91 B).
Full pages: Arcutis Biotherapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.